BACK TO TOP
KSE100
162,994.17
-2829.70
(-1.71%)
KSE100PR
50,055.96
-904.54
(-1.77%)
ALLSHR
97,525.91
-1634.98
(-1.65%)
KSE30
49,090.22
-1011.73
(-2.02%)
KMI30
234,097.75
-4583.61
(-1.92%)
BKTI
45,458.09
-707.82
(-1.53%)
OGTI
33,162.89
-962.44
(-2.82%)
KMIALLSHR
63,284.57
-1151.00
(-1.79%)
PSXDIV20
75,490.58
-1377.65
(-1.79%)
UPP9
58,049.25
-942.50
(-1.60%)
NITPGI
43,332.39
-792.23
(-1.80%)
NBPPGI
46,967.95
-1013.90
(-2.11%)
MZNPI
28,770.34
-636.29
(-2.16%)
JSMFI
39,931.62
-968.30
(-2.37%)
ACI
21,015.83
-492.17
(-2.29%)
JSGBKTI
69,363.81
-1058.30
(-1.50%)
HBLTTI
18,290.53
29-04-2026
8.57
(0.05%)
MII30
21,088.47
-408.88
(-1.90%)
GlaxoSmithKline Pakistan Limited
XD
PHARMACEUTICALS
Rs.340.77
-8.39
(-2.40%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Apr 30, 2026 3:49 PM
REG
DFC
CSF
ODL
Open
346.90
High
346.90
Low
335.55
Volume
233,231
CIRCUIT BREAKER
314.24 — 384.08
DAY RANGE
335.55 — 346.90
52-WEEK RANGE ^
293.09 — 459.94
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
349.16
VAR
13.00
HAIRCUT
17.50
P/E Ratio (TTM) **
10.33
1-Year Change * ^
-7.09%
YTD Change * ^
-12.57%
Last update: Thu, Apr 30, 2026 3:35 PM
Open
340.00
High
340.00
Low
340.00
Close
340.00
Change
-2.86%
LDCP
350.00
Volume
1,000
Total Trades
2
CIRCUIT BREAKER
315.00 — 385.00
DAY RANGE
340.00 — 340.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Dmytro OliinykChairperson
Hina MirCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
108,524,094.32
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 29, 2026Transmission of Quarterly Financial Statements for the Period ended March 31, 2026 View   PDF
Apr 27, 2026Financial Results for the Quarter Ended March 31, 2026 View   PDF
Apr 9, 2026Transmission of Annual Financial Statements for the year ended 31-12-2025 View   PDF
Mar 26, 2026Financial Results for the year Ended 2025-12-31 View   PDF
Oct 29, 2025Transmission of Quarterly Report for the period ended September 30, 2025 View   PDF
DateTitleDocument
Apr 30, 2026Certified True Copy of The Resolutions passed by the shareholders in the Annual General Meeting held on April 30, 2026 View   PDF
Apr 20, 2026Board Meeting Quarter 1- 2026 View   PDF
Apr 9, 2026Notice of the Annual General Meeting View   PDF
Apr 8, 2026Prior Publication of Annual General Meeting Notice View   PDF
Mar 18, 2026Board Meeting Quarter 4, 2025 View   PDF
DateTitleDocument
Apr 30, 2026Corporate Briefing Session View   PDF
Apr 23, 2026Notice of Election of Directors View   PDF
Apr 22, 2026Prior Publication of Notice of Election of Directors View   PDF
Apr 22, 2026Miscellaneous Information View   PDF
Apr 21, 2026Miscellaneous Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales65,900,90161,187,50149,661,27741,841,585
Profit after Taxation10,025,3156,536,047533,9532,462,892
EPS31.4820.521.687.73
Q1 2026Q3 2025Q2 2025Q1 2025
Sales17,028,32514,188,00814,720,66715,580,140
Profit after Taxation2,610,7042,037,2852,068,8112,126,547
EPS8.206.406.506.68
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)37.0025.157.0517.40
Net Profit Margin (%)15.2110.681.085.89
EPS Growth (%)53.411,121.43(78.27)(54.02)
PEG0.230.02(0.63)(0.21)

Payouts

Financial Reports